Phio Pharmaceuticals Corp.·4

Dec 5, 4:30 PM ET

Ferrara Robert L 4

4 · Phio Pharmaceuticals Corp. · Filed Dec 5, 2022

Insider Transaction Report

Form 4
Period: 2022-12-02
Transactions
  • Purchase

    Common stock, $0.0001 par value

    2022-12-02$0.41/sh+5,000$2,04130,000 total
Footnotes (2)
  • [F1]This transaction was executed in multiple trades at prices ranging from $0.4075 to $0.4089. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]Includes shares of common stock underlying unvested restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION